IPPF Launches 2020 Corporate Council On January 1st, the IPPF launched the 2020 Corporate Council, a collection of top stakeholders that are committed to facilitating collaboration and information exchange among patients, the IPPF, key opinion leaders, health-related organizations, and industry. We believe that only through an open and cooperative collaboration among all stakeholders will we effectively be able to address issues facing the pemphigus and pemphigoid (P/P) community. The IPPF Corporate Council will focus on three areas of emphasis: access, advocacy, and awareness. Within these focus areas, the IPPF Corporate Council will develop and support activities and programs that ensure the IPPF fulfills its mission of improving the quality of life for all people affected by P/P through early diagnosis and support. Membership in the IPPF Corporate Council will demonstrate an organization's leadership and commitment to addressing the challenges facing our patients. Involvement in the Council will also provide the IPPF with an extended network of expertise and insight to ensure that we continue to address the unmet needs of all patients. The Corporate Council will provide hope and support by: • Enhancing awareness, knowledge, and attention of P/P in society and among key audiences • Organizing the IPPF community to drive progress in advocacy, awareness, research, drug development, and access to care • Encouraging an industry, academic, and community collaborative investment in, and development of, new/improved treatments and therapies • Promoting more effective identification, diagnosis, and treatment of P/P to improve patient experiences/outcomes
Please join us in welcoming our newest members to the 2020 IPPF Corporate Council:
